Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Mysteries Of Circadian Rhythms Revealed By Fungus
The fuzzy pale mold that lines the glass tubes in Dr. Yi Liu"s lab doesn"t look much like a clock.
generic viagra online
Newly Published Article Details How PGS Techniques Directly Effect Successful Pregnancy Outcomes
A group of fertility experts, who pioneered the development of Preimplantation Genetic Screening (PGS), are sharing the step-by-step best practices and explaining what errors can be made along the way.
News of the day
Aiming For Early Diagnosis For ADHD And Parkinson's Disease
Eye movement tests developed by Queen"s University researchers to aid in understanding childhood brain development and healthy aging may also help in the diagnosis of Attention Deficit Hyperactivity Disorder and detecting the early onset of Parkinson"s disease. The project has received close to $1 million in recent funding from the Canadian Institutes of Health Research (CIHR).
Health Insurance

The National Organization For Rare Disorders Applauds Collins Nomination

The National Organization for Rare Disorders (NORD) said that the nomination by President Obama of Francis S. Collins, M.D., Ph.D., to be the next Director of the National Institutes of Health (NIH), represents "an excellent choice to provide leadership to the NIH." Peter Saltonstall, President and CEO of NORD, said: "Dr. Collins has always been an ardent supporter of NORD and understands the concerns of the 30 million Americans with rare diseases. He recently spoke at NORD"s policy summit and presented a cohesive and articulate view of how to overcome the obstacles facing the development of more treatments for rare diseases." Saltonstall added: "Dr. Collins demonstrated in his oversight of the National Human Genome Research Institute that he is an excellent administrator. His earlier research demonstrates that he is on the frontiers of science and medical progress. He is an excellent choice to provide leadership to the NIH. We look forward to continuing to work with Dr. Collins and to encouraging further NIH commitment to research into new treatments for patients with rare diseases." The National Organization for Rare Disorders


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009